Trial intelligence / Profile preview

Compound betamethasone injection for pain after arthroscopic release of elbow stiffness

ChiCTR2400091750Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Nov 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of betamethasone in None (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Postoperative pain (VAS) at 1 day. Planned start Nov 2024; status: not yet recruiting.

02

Drugs

betamethasone

Beyond the preview

Go deeper on ChiCTR2400091750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400091750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call